IO Biotech prepares for IPO in the US

Copenhagen-based biotech company IO Biotech seeks a listing in the US, reports Danish financial daily Børsen, referring to a filing that the firm has sent to the US Securities and Exchange Commission (SEC).
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
IO Biotech begins phase III trial with partner MSD
For subscribers
IO Biotech puts down roots in USA and hires new CSO
For subscribers